HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing

Virology

Volumn 405, Issue 2, 2010, Pages 539-547

  Audsley, Jennifer ^a,b   Littlejohn, Margaret ^c   Yuen, Lilly ^c   Sasadeusz, Joe ^b   Ayres, Anna ^c   Desmond, Christopher ^b   Spelman, Tim ^d   Lau, George ^e,f   Matthews, Gail V ^g   Avihingsanon, Anchalee ^h   Seaberg, Eric ⁱ   Philp, Frances ⁱ   Saulynas, Melissa ⁱ   Ruxrungtham, Kiat ^h   Dore, Gregory J ^e   Locarnini, Stephen A ^c   Thio, Chloe L ^j   Lewin, Sharon R ^a,b,d   Revill, Peter A ^c,j,k  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d BURNET INSTITUTE   (Australia)

^e Humanity and Health Liver Clinic   (Hong Kong)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j MONASH UNIVERSITY   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Genomic length sequencing; HIV HBV co infection; PreHAART

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE SEQUENCE; GENETIC ANALYSIS; GENOMIC LENGTH SEQUENCING; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS GENOME; VIRUS MUTATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; FEMALE; GENOME, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN PRECURSORS; SEQUENCE ANALYSIS, DNA;

HEPATITIS B VIRUS;

EID: 77955659226     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.038     Document Type: Article

References (67)

1. Abe K., Thung S.N., Wu H.C., Tran T.T., Le Hoang P., Truong K.D., Inui A., Jang J.J., Su I.J. Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci. 2009, 100(12):2249-2254.
2. Allen M.I., Deslauriers M., Andrews C.W., Tipples G.A., Walters K.-A., Tyrrell D.L., Brown N., Group L.C.I., Condreay L.D. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology 1998, 27(6):1670-1677.
3. Arnold C., Clewley J.P. From ABI sequence data to LASERGENE's EDITSEQ. Meth. Mol. Biol. 1997, 70:65-74.
4. Ayres A., Locarnini S., Bartholomeusz A. HBV genotyping and analysis for unique mutations. Meth. Mol. Med. 2004, 95:125-149.
5. Bartholomeusz A., Locarnini S., Ayres A., Thompson G., Sozzi V., Angus P., Sievert W., Sasadeusz J., Chalmers D., Cooper M. Molecular modelling of hepatitis B virus polymerase and adefovir resistance identifies three clusters of mutations. Hepatology 2004, 40(S4):246A.
6. Bläckberg J., Kidd-Ljunggren K. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma. J. Med. Virol. 2003, 71(1):18-23.
7. Bock C.T., Tillmann H.L., Maschek H.J., Manns M.P., Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 1997, 113(6):1976-1982.
8. Bonacini M., Lin H.J., Hollinger F.B. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J. Acquir. Immune Defic. Syndr. 2001, 26(4):340-344.
9. Bruss V., Ganem D. Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J. Virol. 1991, 65(7):3813-3820.
10. Buckwold V.E., Xu Z., Chen M., Yen T.S., Ou J.H. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J. Virol. 1996, 70(9):5845-5851.
11. Carman W.F., Hadziyannis S., McGarvey M.J., Jacyna M.R., Karayiannis P., Makris A., Thomas H.C. Mutation preventing formation of Hepatitis B e antigen in patients with chronic Hepatitis B infection. Lancet 1989, 334(8663):588-591.
12. Chang J.J., Wightman F., Bartholomeusz A., Ayres A., Kent S.J., Sasadeusz J., Lewin S.R. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J. Virol. 2005, 79(5):3038-3051.
13. Chang J.J., Alexander J.V.T., Kumar V., Stephen J.K., Paul U.C., Fiona W., Paul D., Stephen A.L., Sharon R.L. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 2007, 46(5):1332-1340.
14. Chen C.-H., Lee C.-M., Lu S.-N., Changchien C.-S., Eng H.-L., Huang C.-M., Wang J.-H., Hung C.-H., Hu T.-H. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J. Clin. Microbiol. 2005, 43(12):6000-6006.
15. Chen B.-F., Liu C.-J., Jow G.-M., Chen P.-J., Kao J.-H., Chen D.-S. High Prevalence and Mapping of Pre-S Deletion in Hepatitis B Virus Carriers With Progressive Liver Diseases. Gastroenterology 2006, 130(4):1153-1168.
16. Chen C.-H., Hung C.-H., Lee C.-M., Hu T.-H., Wang J.-H., Wang J.-C., Lu S.-N., Changchien C.-S. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 2007, 133(5):1466-1474.
17. Chen C.-H., Lee C.-M., Hung C.-H., Hu T.-H., Wang J.-H., Wang J.-C., Lu S.-N., Changchien C.-S. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study. Liver Int. 2007, 27(6):806-815.
18. Chen C.H., Changchien C.S., Lee C.M., Hung C.H., Hu T.H., Wang J.H., Wang J.C., Lu S.N. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J. Infect. Dis. 2008, 198(11):1634-1642.
19. Clewley J.P., Arnold C. MEGALIGN. The multiple alignment module of LASERGENE. Meth. Mol. Biol. 1997, 70:119-129.
20. Colin J., Cazals-Hatem D., Loriot M., Martinot-Peignoux M., Pham B., Auperin A., Degott C., Benhamou J., Erlinger S., Valla D., Marcellin P. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999, 29(4):1306-1310.
21. Crane M., Oliver B., Matthews G., Avihingsanon A., Ubolyam S., Markovska V., Chang J.J., Dore Gregory J., Price P., Visvanathan K., French M., Ruxrungtham K., Lewin Sharon R. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV) coinfected individuals after the initiation of HBV active antiretroviral therapy. J. Infect. Dis. 2009, 199(7):974-981.
22. Desmond C.P., Bartholomeusz A., Gaudieri S., Revill P.A., Lewin S.R. A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics. Antivir. Ther. 2008, 13(2):161-175.
23. Du H., Li T., Zhang H.-Y., He Z.-P., Dong Q.-M., Duan X.-Z., Zhuang H. Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection. Liver Int. 2007, 27(2):240-246.
24. Fan Y.-F., Lu C.-C., Chen W.-C., Yao W.-J., Wang H.-C., Chang T.-T., Lei H.-Y., Shiau A.-L., Su I.-J. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 2001, 33(1):277-286.
25. Fang Z.-L., Sabin C.A., Dong B.-Q., Wei S.-C., Chen Q.-Y., Fang K.-X., Yang J.-Y., Huang J., Wang X.-Y., Harrison T.J. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J. Gen. Virol. 2008, 89(11):2882-2890.
26. Fattovich G., Bortolotti F., Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J. Hepatol. 2008, 48(2):335-352.
27. Funk M.L., Rosenberg D.M., Lok A.S.F. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J. Viral Hepat. 2002, 9(1):52-61.
28. Gilson R.J., Hawkins A.E., Beecham M.R., Ross E., Waite J., Briggs M., McNally T., Kelly G.E., Tedder R.S., Weller I.V. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997, 11(5):597-606.
29. Gunther S., Li B.C., Miska S., Kruger D.H., Meisel H., Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J. Virol. 1995, 69(9):5437-5444.
30. Gunther S., Piwon N., Will H. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) ->T, A(1762) ->T and G(1764) ->A mutations in the core promoter. J. Gen. Virol. 1998, 79(2):375-380.
31. Günther S., Piwon N., Jung A., Iwanska A., Schmitz H., Will H. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Virology 2000, 273(2):286-299.
32. Hsieh Y.-H., Su I.-J., Wang H.-C., Chang W.-W., Lei H.-Y., Lai M.-D., Chang W.-T., Huang W. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 2004, 25(10):2023-2032.
33. Huy T.T., Ushijima H., Quang V.X., Win K.M., Luengrojanakul P., Kikuchi K., Sata T., Abe K. Genotype C of hepatitis B virus can be classified into at least two subgroups. J. Gen. Virol. 2004, 85(Pt 2):283-292.
34. Kellerman S.E., Hanson D.L., McNaghten A.D., Fleming P.L. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J. Infect. Dis. 2003, 188(4):571-577.
35. Kirishima T., Okanoue T., Daimon Y., Itoh Y., Nakamura H., Morita A., Toyama T., Minami M. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J. Hepatol. 2002, 37(2):259-265.
36. Kobayashi S., Ide T., Sata M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J. Hepatol. 2001, 34(4):584-586.
37. Konopnicki D., Mocroft A., de Wit S., Antunes F., Ledergerber B., Katlama C., Zilmer K., Vella S., Kirk O., Lundgren J.D. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005, 19(6):593-601.
38. Kosakovsky Pond S.L., Frost S.D. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 2005, 22(5):1208-1222.
39. Lauer U., Weiss L., Hofschneider P.H., Kekule A.S. The hepatitis B virus pre-S/S(t) transactivator is generated by 3' truncations within a defined region of the S gene. J. Virol. 1992, 66(9):5284-5289.
40. Lim S.G., Cheng Y., Guindon S., Seet B.L., Lee L.Y., Hu P., Wasser S., Peter F.J., Tan T., Goode M., Rodrigo A.G. Viral quasi-species evolution during hepatitis Be antigen seroconversion. Gastroenterology 2007, 133(3):951-958.
41. Lincoln D., Petoumenos K., Dore G.J. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med. 2003, 4(3):241-249.
42. Lindh M., Hannoun C., Dhillon Amar P., Norkrans G., Horal P. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J. Infect. Dis. 1999, 179(4):775-782.
43. Liu C.-J., Kao J.-H., Shau W.-Y., Chen P.-J., Lai M.-Y., Chen D.-S. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J. Med. Virol. 2002, 68(1):50-59.
44. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., Ingersoll R., Sheppard H.W., Ray S.C. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 1999, 73(1):152-160.
45. Märschenz S., Endres A.-S., Brinckmann A., Heise T., Kristiansen G., Nürnberg P., Krüger D.H., Günther S., Meisel H. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology 2006, 131(3):765-780.
46. Moriyama K., Okamoto H., Tsuda F., Mayumi M. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 1996, 226(2):269-280.
47. Mun H.-S., Lee S.-A., Jee Y., Kim H., Park J.-H., Song B.-C., Yoon J.-H., Kim Y.J., Lee H.-S., Hyun J.-W., Hwang E.-S., Kook Y.-H., Kim B.-J. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J. Med. Virol. 2008, 80(7):1189-1194.
48. Norder H., Courouce A.M., Coursaget P., Echevarria J.M., Lee S.D., Mushahwar I.K., Robertson B.H., Locarnini S., Magnius L.O. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004, 47(6):289-309.
49. Ockenga J., Tillmann H.L., Trautwein C., Stoll M., Manns M.P., Schmidt R.E. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J. Hepatol. 1997, 27(1):18-24.
50. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., Miyakawa Y., Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J. Virol. 1994, 68(12):8102-8110.
51. Osiowy C., Giles E., Tanaka Y., Mizokami M., Minuk G.Y. Molecular evolution of hepatitis B virus over 25 years. J. Virol. 2006, 80(21):10307-10314.
52. Page R.D. TreeView: an application to display phylogenetic trees on personal computers. CABIOS 1996, 12(4):357-358.
53. Pond S.L., Frost S.D. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 2005, 21(10):2531-2533.
54. Pond S.L., Frost S.D., Muse S.V. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21(5):676-679.
55. Preikschat P., Günther S., Reinhold S., Will H., Budde K., Neumayer H.H., Krüger D.H., Meisel H. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 2002, 35(2):466-477.
56. Revill P.A., Littlejohn M., Ayres A., Yuen L., Colledge D., Bartholomeusz A., Sasaduesz J., Lewin S.R., Dore G.J., Matthews G.V., Thio C.L., Locarnini S.A. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals. AIDS 2007, 21(13):1701-1710.
57. Song B.-C., Kim S.-H., Kim H., Ying Y.-H., Kim H.-J., Kim Y.-J., Yoon J.-H., Lee H.-S., Cha C.-Y., Kook Y.-H., Kim B.-J. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J. Med. Virol. 2005, 76(2):194-202.
58. Tanaka Y., Mukaide M., Orito E., Yuen M.-F., Ito K., Kurbanov F., Sugauchi F., Asahina Y., Izumi N., Kato M., Lai C.-L., Ueda R., Mizokami M. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J. Hepatol. 2006, 45(5):646-653.
59. Tatematsu K., Tanaka Y., Kurbanov F., Sugauchi F., Mano S., Maeshiro T., Nakayoshi T., Wakuta M., Miyakawa Y., Mizokami M. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J. Virol. 2009, 83(20):10538-10547.
60. Thio C.L., Seaberg E.C., Skolasky R., Phair J., Visscher B., Munoz A., Thomas D.L. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002, 360(9349):1921-1926.
61. Thomas D.L., Cannon R.O., Shapiro C.N., Hook E.W., Alter M.J., Quinn T.C. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J. Infect. Dis. 1994, 169(5):990-995.
62. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25(24):4876-4882.
63. Tong M.J., Blatt L.M., Kao J.H., Cheng J.T., Corey W.G. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers. Liver Int. 2007, 27(10):1356-1363.
64. Trautwein C., Schrem H., Tillmann H.L., Kubicka S., Walker D., Böker K.H., Maschek H.J., Pichlmayr R., Manns M.P. Hepatitis B virus mutations in the pre-S genome before and after liver transplantatio. Hepatology 1996, 24(3):482-488.
65. Wang H.C., Wu H.C., Chen C.F., Fausto N., Lei H.Y., Su I.J. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am. J. Pathol. 2003, 163(6):2441-2449.
66. Xu Z., Yen T.S. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J. Virol. 1996, 70(1):133-140.
67. Yuen L.K.W., Ayres A., Littlejohn M., Colledge D., Edgely A., Maskill W.J., Locarnini S.A., Bartholomeusz A. SEQHEPB: A sequence analysis program and relational database system for chronic hepatitis B. Antivir. Res. 2007, 75(1):64-74.